For Hospitals & Nuclear Medicine Departments

Dosimetry that runs
inside your department.

Patient-specific absorbed dose for radioligand therapy and SIRT — implemented with your existing scanner, your existing team, and your existing workflow. No new infrastructure required.

Scroll
PLANET® Dose dosimetry software interface showing voxel dose map
PLANET® Dose
by DOSIsoft · Distributed by Oncosia Scientific
FDA 510(k) CE MDR Class IIb Multi-market cleared
MRT Dosimetry — ¹⁷⁷Lu, ¹³¹I and more
SIRT Dosimetry — ⁹⁰Y, ¹⁶⁶Ho · single and multi-injection
Voxel-based 3D dose maps — organ-at-risk and tumour level
AI-assisted segmentation — Auto Segment & Auto Lesion Detect
Partial Volume Effect correction — Dual Segmentation (CT-VOI + functional VOI) or Recovery Coefficient method
DICOM RT-Dose — import & export for EBRT integration
Multi-cycle consolidation — cumulative dose tracking
PLANET® Dose — Implemented By Oncosia

The software is powerful.
What makes it work is the physics.

PLANET® Dose requires scanner-specific calibration, validated acquisition protocols, and medical physics expertise to produce results you can act on. We provide all three — so you are not buying a tool and then figuring out how to use it alone.

Results within your clinical time window

AI-assisted organ segmentation reduces contouring from 30–45 minutes to a quality-check step. Auto Fit selects the optimal pharmacokinetic model per organ automatically. The full absorbed dose calculation — from SPECT/CT to report — is completed fast enough to inform the next cycle, not document the last one.

No step in the workflow is irreversible

Registration, segmentation, curve fitting, dose calculation — every stage can be revisited and updated without restarting the analysis. Save mid-workflow, reopen later, run multiple studies in parallel. We configure the workflow to match how your department actually operates, not how the software was designed to be used in ideal conditions.

A question on methodology is not a support ticket

When you have a question about acquisition protocol, dose calculation approach, or how to handle an unusual patient dataset — you reach a medical physicist who knows your setup. Not a generic helpdesk. We remain the expert resource behind your dosimetry programme for as long as you run it.

PLANET® Dose is developed by DOSIsoft SA, France. Oncosia Scientific is the authorised distribution and implementation partner in Germany and Turkiye. Full technical documentation and regulatory certificates available on request.
How We Work With You

Two models. One level of rigour.

The right model depends on your department's physics capacity and patient volume — not on what is easiest for us to deliver. Both produce the same standard of dosimetry output.

Model 01

Integrated In-House Dosimetry

PLANET® Dose · Implemented & Supported

Your team runs dosimetry in-house using PLANET® Dose — validated for your specific scanner, with your acquisition protocol, and with Oncosia's specialist support behind it. You build internal capability without building from scratch.

PLANET® Dose software licence and implementation by Oncosia
Scanner calibration and phantom validation at your site
Staff training — physicists and nuclear medicine team
Ongoing Expert-to-Expert support and annual workflow revalidation
Learn About PLANET® Dose
Ideal for Departments with a medical physicist who can operate dosimetry software, wanting full in-house control over the analysis workflow.
Model 02

Dosimetry as a Service

Expert-delivered · No software required

You acquire the imaging data. We do everything else — quantification, time-activity curve fitting, absorbed dose calculation, and the final validated report. Delivered before your next treatment cycle.

SPECT/CT or PET/CT data transferred via secure upload
Full organ-at-risk and tumour dosimetry report
Peer-reviewed by medical physicist and nuclear medicine physician
No dosimetry software licence needed at your site
Request DaaS Information
Ideal for Departments starting dosimetry with limited in-house capacity, low patient through-put or sites wanting consistent quality without software overhead.
Clinical Implementation

From no dosimetry infrastructure to a validated workflow.

The department had been running SIRT with Y-90 and Lu-177 PSMA therapy in parallel — each programme with its own workflow. They wanted to extend to post-treatment dosimetry for SIRT, add MRT dosimetry for the Lu-177 programme, and consolidate everything onto a single platform.

From the department
"Voxel-based dosimetry changed how we approach individual patient cases. We are no longer working from estimates — we can see what is actually happening inside them. Oncosia supported us at every step — and we still consult them regularly."
Assoc. Prof. Isa Burak Güney
Assoc. Prof. Isa Burak Güney
Nuclear Medicine Physician · Cukurova University Hospital, Turkiye
The Implementation Journey
01
Remote
Scoping & Protocol Design

We assessed the site's SPECT/CT and PET/CT setup, validated existing acquisition protocols internally, and prepared the IT landscape for PACS integration. A site equipment analysis was completed to prepare for the Lu-177 phantom study.

~1–2 weeks · Preparation
02
On-Site / Remote
Phantom Validation & Scanner Calibration

Phantom study performed on-site following Oncosia standards, aligned with EANM and SNMMI recommendations — including SPECT/CT sensitivity quantification and dose calibrator cross-calibration. Acceptance criteria documented and signed off before first patient.

1 day on-site and remote · Documentation within 1 week
03
On-Site
Software Setup & Staff Training

Workstation installed, connected to hospital IT and PACS. Followed by a theoretical training session, hands-on work with the department's own patient datasets, and joint review of optimal time-point selection.

2 days
04
Remote
Ongoing Support & Annual Revalidation

Specialist access for edge cases, protocol updates as guidance evolves, and annual workflow revalidation to confirm accuracy as scanner performance and software versions change.

Continuous
Clinical Evidence
"Absorbed dose to tumour lesions correlated with volumetric response — and organ doses predicted toxicity. Dosimetry after the first cycle of [¹⁷⁷Lu]Lu-DOTATATE provides clinically actionable information before the next one is given."

Hebert K, et al. Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [¹⁷⁷Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine. J Nucl Med, 2024;65(6):923–930. DOI: 10.2967/jnumed.123.267171

Dosimetry performed using PLANET® Dose with local energy deposition method. Serial post-treatment SPECT/CT at up to three time points. Organ and tumour doses correlated with toxicity and tumour volume response.

Common Questions

Questions we hear before the first conversation.

Specific to clinical routine dosimetry. If yours is not here, it probably comes up in the first call.

Yes. PLANET® Dose is vendor-neutral and works with any reconstructed images. Oncosia assesses whether your existing equipment meets the requirements for the phantom study — and if anything is missing, we can provide it through our managed rental service.
PACS and network configuration is prepared remotely before the on-site visit. During the Installation & Training visit, the PACS connection is established and tested on-site.
Remote support is covered under the CE MDR certification of PLANET® Dose, which includes the required security measures. Data processing agreements can be executed in addition, depending on your institution's specific requirements.
Typically medical physicists and technologists operate PLANET® Dose for acquisition and analysis. Nuclear medicine physicians are often involved in segmentation review and final study approval before documentation. Training scope and duration are aligned to your team's composition during onboarding.
The phantom study establishes scanner-specific sensitivity factors and confirms that your quantitative imaging chain — from acquisition through reconstruction — produces accurate quantification. It is also used to confirm the imaging acquistion protocol of the scanner.
Within our Expert-to-Expert service, we recommend an annual revalidation of each workflow. This includes data quality control and an independent dosimetry analysis by Oncosia, compared against your results to identify any drift or errors. The phantom study should be repeated after major SPECT/CT software or hardware changes, or after 12 months — but once trained, your site staff can conduct it independently.
As early as possible — ideally before the first patient is scheduled. Early involvement allows us to assess your scanner setup, design the acquisition protocol, and complete phantom validation in time.
Get Started

The first conversation costs
nothing and commits nothing.

Tell us what therapy you are running, what your current setup looks like, and what you are trying to achieve. We will tell you honestly what is possible and what it involves.